Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo

Journal of Clinical Investigation

Volumn 117, Issue 4, 2007, Pages 1068-1077

  Rankin, Erinn B ^a   Biju, Mangatt P ^a   Liu, Qingdu ^a   Unger, Travis L ^a   Rha, Jennifer ^a   Johnson, Randall S ^b   Simon, M Celeste ^c   Keith, Brian ^c   Haase, Volker H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2; HYPOXIA INDUCIBLE FACTOR 2ALPHA; PHOSPHOGLYCERATE KINASE; PHOSPHOGLYCERATE KINASE 1; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ALLELE; ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE CONTROL; IN VIVO STUDY; LIVER CELL; MOUSE; NONHUMAN; POLYCYTHEMIA; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; GENE EXPRESSION REGULATION; HEPATOCYTES; HIPPEL-LINDAU DISEASE; LIVER; MICE; MICE, KNOCKOUT; POLYCYTHEMIA VERA; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 34147124264     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI30117     Document Type: Article

References (70)

1. Ebert, B.L., and Bunn, H.F. 1999. Regulation of the erythropoietin gene. Blood. 94:1864-1877.
2. Wu, H., Lee, S.H., Gao, J., Liu, X., and Iruela-Arispe, M.L. 1999. Inactivation of erythropoietin leads to defects in cardiac morphogenesis. Development. 126:3597-3605.
3. Wu, H., Liu, X., Jaenisch, R., and Lodish, H.F. 1995. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell. 83:59-67.
4. Zanjani, E.D., Ascensao, J.L., McGlave, P.B., Banisadre, M., and Ash, R.C. 1981. Studies on the liver to kidney switch of erythropoietin production. J. Clin. Invest. 67:1183-1188.
5. Dame, C., et al. 1998. Erythropoietin mRNA expression in human fetal and neonatal tissue. Blood. 92:3218-3225.
6. Moritz, K.M., Lim, G.B., and Wintour, E.M. 1997. Developmental regulation of erythropoietin and erythropoiesis. Am. J. Physiol. 273:R1829-R1844.
7. Eckardt, K.U., Ratcliffe, P.J., Tan, C.C., Bauer, C., and Kurtz, A. 1992. Age-dependent expression of the erythropoietin gene in rat liver and kidneys. J. Clin. Invest. 89:753-760.
8. Koury, S.T., Bondurant, M.C., Koury, M.J., and Semenza, G.L. 1991. Localization of cells producing erythropoietin in murine liver by in situ hybridization. Blood. 77:2497-2503.
9. Fandrey, J. 2004. Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286:R977-R988.
10. Eckardt, K.U., and Kurtz, A. 2005. Regulation of erythropoietin production. Eur. J. Clin. Invest. 35(Suppl. 3):13-19.
11. Semenza, G.L., and Wang, G.L. 1992. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12:5447-5454.
12. Wang, G.L., Jiang, B.H., Rue, E.A., and Semenza, G.L. 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. U. S. A. 92:5510-5514.
13. Wang, G.L., and Semenza, G.L. 1995. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270:1230-1237.
14. Kewley, R.J., Whitelaw, M.L., and Chapman-Smith, A. 2004. The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. Int. J. Biochem. Cell Biol. 36:189-204.
15. Wenger, R.H. 2002. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J. 16:1151-1162.
16. Semenza, G.L. 2001. HIF-1 and mechanisms of hypoxia sensing. Curr. Opin. Cell Biol. 13:167-171.
17. Schofield, C.J., and Ratcliffe, P.J. 2004. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 5:343-354.
18. Semenza, G.L., Koury, S.T., Nejfelt, M.K., Gearhart, J.D., and Antonarakis, S.E. 1991. Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 88:8725-8729.
19. Warnecke, C., et al. 2004. Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells. FASEB J. 18:1462-1464.
20. Stolze, I., et al. 2002. Hypoxia-inducible erythropoietin gene expression in human neuroblastoma cells. Blood. 100:2623-2628.
21. Tam, B.Y., et al. 2006. VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis. Nat. Med. 12:793-800.
22. Yoon, D., et al. 2006. HIF-1alpha-deficiency results in dysregulated EPO signaling and iron homeostasis in mouse development. J. Biol. Chem. 281:25703-25711.
23. Grimm, C., et al. 2002. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat. Med. 8:718-724.
24. Rankin, E.B., et al. 2005. Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice. Mol. Cell. Biol. 25:3163-3172.
25. Kietzmann, T., Cornesse, Y., Brechtel, K., Modaressi, S., and Jungermann, K. 2001. Perivenous expression of the mRNA of the three hypoxia-inducible factor alpha-subunits, HIF1alpha, HIF2alpha and HIF3alpha, in rat liver. Biochem. J. 354:531-537.
26. Stroka, D.M., et al. 2001. HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J. 15:2445-2453.
27. Wiesener, M.S., et al. 2003. Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J. 17:271-273.
28. Ryan, H.E., Lo, J., and Johnson, R.S. 1998. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 17:3005-3015.
29. Gruber, M., et al. 2007. Acute postnatal ablation of Hif-2alpha results in anemia. Proc. Natl. Acad. Sci. U. S. A. 104:2301-2306.
30. Postic, C., et al. 1999. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J. Biol. Chem. 274:305-315.
31. Kaelin, W.G., Jr. 2002. Molecular basis of the VHL hereditary cancer syndrome. Nat. Rev. Cancer. 2:673-682.
32. Haase, V.H., Glickman, J.N., Socolovsky, M., and Jaenisch, R. 2001. Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc. Natl. Acad. Sci. U. S. A. 98:1583-1588.
33. Rolfs, A., Kvietikova, I., Gassmann, M., and Wenger, R.H. 1997. Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1. J. Biol. Chem. 272:20055-20062.
34. Hu, C.J., Wang, L.Y., Chodosh, L.A., Keith, B., and Simon, M.C. 2003. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol. Cell. Biol. 23:9361-9374.
35. Raval, R.R., et al. 2005. Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol. Cell. Biol. 25:5675-5686.
36. Socolovsky, M., et al. 2001. Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. Blood. 98:3261-3273.
37. Criswell, K.A., Sulkanen, A.P., Hochbaum, A.F., and Bleavins, M.R. 2000. Effects of phenylhydrazine or phlebotomy on peripheral blood, bone marrow and erythropoietin in Wistar rats. J. Appl. Toxicol. 20:25-34.
38. Milkiewicz, M., Pugh, C.W., and Egginton, S. 2004. Inhibition of endogenous HIF inactivation induces angiogenesis in ischaemic skeletal muscles of mice. J. Physiol. 560:21-26.
39. Postic, C., and Magnuson, M.A. 2000. DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis. 26:149-150.
40. Semenza, G.L., Nejfelt, M.K., Chi, S.M., and Antonarakis, S.E. 1991. Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc. Natl. Acad. Sci. U. S. A. 88:5680-5684.
41. Scortegagna, M., et al. 2005. HIF-2alpha regulates murine hematopoietic development in an erythropoietin-dependent manner. Blood. 105:3133-3140.
42. Morita, M., et al. 2003. HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin. EMBO J. 22:1134-1146.
43. Maxwell, P.H., et al. 1993. Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int. 44:1149-1162.
44. Rosenberger, C., et al. 2002. Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys. J. Am. Soc. Nephrol. 13:1721-1732.
45. Suzuki, N., et al. 2006. Regulation and essential role of the erythropoietin gene in the liver [abstract]. Ann. Hematol. 85:656.
46. Tan, C.C., Eckardt, K.U., and Ratcliffe, P.J. 1991. Organ distribution of erythropoietin messenger RNA in normal and uremic rats. Kidney Int. 40:69-76.
47. Fandrey, J., and Bunn, H.F. 1993. In vivo and in vitro regulation of erythropoietin mRNA: measurement by competitive polymerase chain reaction. Blood. 81:617-623.
48. Marti, H.H., et al. 1996. Erythropoietin gene expression in human, monkey and murine brain. Eur. J. Neurosci. 8:666-676.
49. Iyer, N.V., et al. 1998. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 12:149-162.
50. Tian, H., Hammer, R.E., Matsumoto, A.M., Russell, D.W., and McKnight, S.L. 1998. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev. 12:3320-3324.
51. Peng, J., Zhang, L., Drysdale, L., and Fong, G.H. 2000. The transcription factor EPAS-1/hypoxia inducible factor 2alpha plays an important role in vascular remodeling. Proc. Natl. Acad. Sci. U. S. A. 97:8386-8391.
52. Compernolle, V., et al. 2002. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat. Med. 8:702-710.
53. Scortegagna, M., et al. 2003. Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- mice. Nat. Genet. 35:331-340.
54. Ema, M., et al. 1997. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc. Natl. Acad. Sci. U. S. A. 94:4273-4278.
55. Blanchard, K.L., Acquaviva, A.M., Galson, D.L., and Bunn, H.F. 1992. Hypoxic induction of the human erythropoietin gene: cooperation between the promoter and enhancer, each of which contains steroid receptor response elements. Mol. Cell. Biol. 12:5373-5385.
56. Galson, D.L., et al. 1995. The orphan receptor hepatic nuclear factor 4 functions as a transcriptional activator for tissue-specific and hypoxia-specific erythropoietin gene expression and is antagonized by EAR3/COUP-TF1. Mol. Cell. Biol. 15:2135-2144.
57. Aprelikova, O., Wood, M., Tackett, S., Chandramouli, G.V., and Barrett, J.C. 2006. Role of ETS transcription factors in the hypoxia-inducible factor-2 target gene selection. Cancer Res. 66:5641-5647.
58. Ang, S.O., et al. 2002. Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat. Genet. 32:614-621.
59. Pastore, Y., et al. 2003. Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia. Am. J. Hum. Genet. 73:412-419.
60. Percy, M.J., et al. 2006. A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Proc. Natl. Acad. Sci. U. S. A. 103:654-659.
61. Appelhoff, R.J., et al. 2004. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J. Biol. Chem. 279:38458-38465.
62. Wang, Q.J., et al. 2005. Induction of renal and extrarenal erythropoietin production by orally bioavailable HIF prolyl hydroxylase inhibitors [abstract]. J. Am. Soc. Nephrol. 16:483A.
63. Liu, D.Y., et al. 2005. Novel and beneficial pharmacodynamic properties of endogenous EPO and complete erythropoiesis induced by selective HIF prolyl hydroxylase inhibitors [abstract]. J. Am. Soc. Nephrol. 16:761A.
64. Langsetmo, I., et al. 2005. FG-2216 corrects anemia and improves iron utilization in a rat model of anemia of chronic disease: comparison to darbepoetin [abstract]. J. Am. Soc. Nephrol. 16:481A.
65. Lok, C.N., and Ponka, P. 1999. Identification of a hypoxia response element in the transferrin receptor gene. J. Biol. Chem. 274:24147-24152.
66. Tacchini, L., Bianchi, L., Bernelli-Zazzera, A., and Cairo, G. 1999. Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation. J. Biol. Chem. 274:24142-24146.
67. Ryan, H.E., et al. 2000. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res. 60:4010-4015.
68. Rankin, E.B., Tomaszewski, J.E., and Haase, V.H. 2006. Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor. Cancer Res. 66:2576-2583.
69. Walisser, J.A., Bunger, M.K., Glover, E., Harstad, E.B., and Bradfield, C.A. 2004. Patent ductus venosus and dioxin resistance in mice harboring a hypomorphic Arnt allele. J. Biol. Chem. 279:16326-16331.
70. Laird, P.W., et al. 1991. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19:4293.